{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T13:32:03Z","timestamp":1766323923991,"version":"3.48.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,21]]},"DOI":"10.7759\/cureus.99768","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T13:29:57Z","timestamp":1766323797000},"source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant Chemotherapy in Children With Enucleated Retinoblastoma and Histopathologic High-Risk Features: Survival Outcomes From a Single Institution in a Middle-Income Country"],"prefix":"10.7759","author":[{"given":"Amaranto","family":"Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alejandra","family":"\u00c1gredo Lucio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(87)33436-0","article-title":"Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation","volume":"94","author":"Kopelman JE","year":"1987","unstructured":"Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987, 94:371-7. 10.1016\/s0161-6420(87)33436-0","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.0.CO;2-3","article-title":"Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution","volume":"77","author":"Khelfaoui F","year":"1996","unstructured":"Khelfaoui F, Validire P, Auperin A, et al.. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996, 77:1206-13. 10.1002\/(SICI)1097-0142(19960315)77:6&lt;1206::AID-CNCR30&gt;3.0.CO;2-3","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004250","article-title":"High-risk histopathological features of retinoblastoma following primary enucleation: a global study of 1,426 patients from 5 continents","volume":"44","author":"Kaliki S","year":"2024","unstructured":"Kaliki S, Vempuluru VS, Bakal KR, et al.. High-risk histopathological features of retinoblastoma following primary enucleation: a global study of 1,426 patients from 5 continents. Retina. 2024, 44:2105-15. 10.1097\/IAE.0000000000004250","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.5.729","article-title":"Practical approach to management of retinoblastoma","volume":"122","author":"Shields CL","year":"2004","unstructured":"Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004, 122:729-35. 10.1001\/archopht.122.5.729","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20606","article-title":"A proposal for an international retinoblastoma staging system","volume":"47","author":"Chantada G","year":"2006","unstructured":"Chantada G, Doz F, Antoneli CB, et al.. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006, 47:801-5. 10.1002\/pbc.20606","journal-title":"Pediatr Blood Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5858\/133.8.1199","article-title":"Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma","volume":"133","author":"Sastre X","year":"2009","unstructured":"Sastre X, Chantada GL, Doz F, et al.. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009, 133:1199-202. 10.5858\/133.8.1199","journal-title":"Arch Pathol Lab Med"},{"key":"ref7","article-title":"Retinoblastoma","author":"Mallipatna A","year":"2017","unstructured":"Mallipatna A, Gallie BL, Ch\u00e9vez-Barrios P, et al.. Retinoblastoma. AJCC Cancer Staging Manual. Amin MB, Edge SB (ed): Springer, 2017. 819-31."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-015-0121-9","article-title":"Management of retinoblastoma in children: current status","volume":"17","author":"Chantada G","year":"2015","unstructured":"Chantada G, Schaiquevich P. Management of retinoblastoma in children: current status. Paediatr Drugs. 2015, 17:185-98. 10.1007\/s40272-015-0121-9","journal-title":"Paediatr Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.037044","article-title":"Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?","volume":"88","author":"Chantada GL","year":"2004","unstructured":"Chantada GL, Dunkel IJ, de D\u00e1vila MT, Abramson DH. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?. Br J Ophthalmol. 2004, 88:1069-73. 10.1136\/bjo.2003.037044","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3962","article-title":"Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation","volume":"31","author":"Aerts I","year":"2013","unstructured":"Aerts I, Sastre-Garau X, Savignoni A, et al.. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation. J Clin Oncol. 2013, 31:1458-63. 10.1200\/JCO.2012.42.3962","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.1501","article-title":"Treatment of nonmetastatic unilateral retinoblastoma in children","volume":"136","author":"P\u00e9rez V","year":"2018","unstructured":"P\u00e9rez V, Sampor C, Rey G, et al.. Treatment of nonmetastatic unilateral retinoblastoma in children. JAMA Ophthalmol. 2018, 136:747-52. 10.1001\/jamaophthalmol.2018.1501","journal-title":"JAMA Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01808","article-title":"Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a Children\u2019s Oncology Group study","volume":"37","author":"Ch\u00e9vez-Barrios P","year":"2019","unstructured":"Ch\u00e9vez-Barrios P, Eagle RC Jr, Krailo M, et al.. Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a Children\u2019s Oncology Group study. J Clin Oncol. 2019, 37:2883-91. 10.1200\/JCO.18.01808","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22504","article-title":"Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma","volume":"55","author":"Dunkel IJ","year":"2010","unstructured":"Dunkel IJ, Khakoo Y, Kernan NA, et al.. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 2010, 55:55-9. 10.1002\/pbc.22504","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2015.04.002","article-title":"Treatment of retinoblastoma: the Institut Curie experience on a series of 730 patients (1995 to 2009)","volume":"38","author":"Lumbroso-Le Rouic L","year":"2015","unstructured":"Lumbroso-Le Rouic L, Savignoni A, Levy-Gabriel C, et al.. Treatment of retinoblastoma: the Institut Curie experience on a series of 730 patients (1995 to 2009). J Fr Ophtalmol. 2015, 38:535-41. 10.1016\/j.jfo.2015.04.002","journal-title":"J Fr Ophtalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000861","article-title":"Optic nerve infiltration by retinoblastoma: predictive clinical features and outcome","volume":"36","author":"Kaliki S","year":"2016","unstructured":"Kaliki S, Tahiliani P, Mishra DK, Srinivasan V, Ali MH, Reddy VA. Optic nerve infiltration by retinoblastoma: predictive clinical features and outcome. Retina. 2016, 36:1177-83. 10.1097\/IAE.0000000000000861","journal-title":"Retina"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306222","article-title":"Neoadjuvant\/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre","volume":"99","author":"K\u00fcnkele A","year":"2015","unstructured":"K\u00fcnkele A, Wilm J, Holdt M, et al.. Neoadjuvant\/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. Br J Ophthalmol. 2015, 99:949-53. 10.1136\/bjophthalmol-2014-306222","journal-title":"Br J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00141","article-title":"Delayed enucleation with neoadjuvant chemotherapy in advanced intraocular unilateral retinoblastoma: AHOPCA II, a prospective, multi-institutional protocol in Central America","volume":"37","author":"Luna-Fineman S","year":"2019","unstructured":"Luna-Fineman S, Chantada G, Alejos A, et al.. Delayed enucleation with neoadjuvant chemotherapy in advanced intraocular unilateral retinoblastoma: AHOPCA II, a prospective, multi-institutional protocol in Central America. J Clin Oncol. 2019, 37:2875-82. 10.1200\/JCO.18.00141","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.168062","article-title":"Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators","volume":"94","author":"Canturk S","year":"2010","unstructured":"Canturk S, Qaddoumi I, Khetan V, et al.. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010, 94:1432-6. 10.1136\/bjo.2009.168062","journal-title":"Br J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.174","article-title":"Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome","volume":"127","author":"Cuenca A","year":"2009","unstructured":"Cuenca A, Giron F, Castro D, Fandi\u00f1o A, Guitter M, de D\u00e1vila MT, Chantada G. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome. Arch Ophthalmol. 2009, 127:1006-10. 10.1001\/archophthalmol.2009.174","journal-title":"Arch Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28963","article-title":"Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)","volume":"68","author":"Dittner-Moormann S","year":"2021","unstructured":"Dittner-Moormann S, Reschke M, Abbink FC, et al.. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatr Blood Cancer. 2021, 68:e28963. 10.1002\/pbc.28963","journal-title":"Pediatr Blood Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000167","article-title":"Anterior segment invasion in retinoblastoma: is it a risk factor for extraocular relapse?","volume":"36","author":"Baroni LV","year":"2014","unstructured":"Baroni LV, Sampor C, Fandi\u00f1o A, Solernou V, Demirdjian G, de Davila MT, Chantada GL. Anterior segment invasion in retinoblastoma: is it a risk factor for extraocular relapse?. J Pediatr Hematol Oncol. 2014, 36:e509-12. 10.1097\/MPH.0000000000000167","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22111","article-title":"Anterior chamber invasion in retinoblastoma: not an indication for adjuvant chemotherapy","volume":"58","author":"Sreelakshmi KV","year":"2017","unstructured":"Sreelakshmi KV, Chandra A, Krishnakumar S, Natarajan V, Khetan V. Anterior chamber invasion in retinoblastoma: not an indication for adjuvant chemotherapy. Invest Ophthalmol Vis Sci. 2017, 58:4654-61. 10.1167\/iovs.17-22111","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444965-adjuvant-chemotherapy-in-children-with-enucleated-retinoblastoma-and-histopathologic-high-risk-features-survival-outcomes-from-a-single-institution-in-a-middle-income-country","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T13:29:58Z","timestamp":1766323798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444965-adjuvant-chemotherapy-in-children-with-enucleated-retinoblastoma-and-histopathologic-high-risk-features-survival-outcomes-from-a-single-institution-in-a-middle-income-country"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.99768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}